M. Gninafon

1.6k total citations
40 papers, 769 citations indexed

About

M. Gninafon is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, M. Gninafon has authored 40 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in M. Gninafon's work include Tuberculosis Research and Epidemiology (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and Diagnosis and treatment of tuberculosis (5 papers). M. Gninafon is often cited by papers focused on Tuberculosis Research and Epidemiology (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and Diagnosis and treatment of tuberculosis (5 papers). M. Gninafon collaborates with scholars based in Benin, France and United Kingdom. M. Gninafon's co-authors include Arnaud Trébucq, John Horton, Piero Olliaro, Roxana Rustomjee, Christian Lienhardt, Corinne Merle, Joseph Odhiambo, Katherine Fielding, Christian Perronne and Olivier Lapujade and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M. Gninafon

39 papers receiving 743 citations

Peers

M. Gninafon
Anushka Naidoo South Africa
Maia Kipiani Georgia
Awal Khan United States
James C.M. Brust United States
Sundari Mase United States
Mondira Bhattacharya United States
Gregory Symons South Africa
Andrew Vernon United States
R. Williams United Kingdom
Anushka Naidoo South Africa
M. Gninafon
Citations per year, relative to M. Gninafon M. Gninafon (= 1×) peers Anushka Naidoo

Countries citing papers authored by M. Gninafon

Since Specialization
Citations

This map shows the geographic impact of M. Gninafon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gninafon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gninafon more than expected).

Fields of papers citing papers by M. Gninafon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gninafon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gninafon. The network helps show where M. Gninafon may publish in the future.

Co-authorship network of co-authors of M. Gninafon

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gninafon. A scholar is included among the top collaborators of M. Gninafon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gninafon. M. Gninafon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwoebel, V, Arnaud Trébucq, Zacharie Kashongwe, et al.. (2020). Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries. EClinicalMedicine. 20. 100268–100268. 25 indexed citations
2.
Trébucq, Arnaud, V Schwoebel, Zacharie Kashongwe, et al.. (2017). Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries. The International Journal of Tuberculosis and Lung Disease. 22(1). 17–25. 109 indexed citations
3.
Agodokpessi, G., et al.. (2017). Prévalence des symptômes du syndrome d’apnées obstructives du sommeil (SAOS) à Cotonou, Bénin : données préliminaires de l’étude « EPSASAPLF ». Revue des Maladies Respiratoires. 34. A283–A284. 1 indexed citations
4.
Agodokpessi, G., N Aït-Khaled, M. Gninafon, et al.. (2015). Assessment of a revolving drug fund for essential asthma medicines in Benin. Journal of Pharmaceutical Policy and Practice. 8(1). 12–12. 4 indexed citations
5.
Merle, Corinne, Katherine Fielding, M. Gninafon, et al.. (2014). A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis. New England Journal of Medicine. 371(17). 1588–1598. 262 indexed citations
7.
Agodokpessi, G., et al.. (2014). Profil de sensibilisation aux pneumallergènes des patients suivis pour asthme à Cotonou, Bénin : étude transversale par prick-tests. Revue des Maladies Respiratoires. 32(9). 930–935. 7 indexed citations
8.
Adè, S., Arnaud Trébucq, A D Harries, et al.. (2013). MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin. Public Health Action. 3(2). 160–165. 3 indexed citations
9.
Adè, S., A D Harries, Arnaud Trébucq, et al.. (2013). The burden and outcomes of childhood tuberculosis in Cotonou, Benin. Public Health Action. 3(1). 15–19. 14 indexed citations
10.
Gninafon, M., et al.. (2013). Management of asthma in Benin: the challenge of loss to follow-up. Public Health Action. 3(1). 76–80. 16 indexed citations
11.
Dlodlo, R. A., et al.. (2013). Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin. The International Journal of Tuberculosis and Lung Disease. 17(11). 1405–1410. 7 indexed citations
12.
Robert, J., et al.. (2012). Assessment of Organizational Measures to Prevent Nosocomial Tuberculosis in Health Facilities of 4 Sub-Saharan Countries in 2010. Infection Control and Hospital Epidemiology. 34(2). 190–194. 11 indexed citations
13.
Agodokpessi, G., Gabriel Adè, S. Adè, et al.. (2012). Management of tuberculosis and HIV co-infection in Cotonou, Benin. Médecine et Maladies Infectieuses. 42(11). 561–566. 5 indexed citations
14.
Merle, Corinne, Charalambos Sismanidis, Oumou Bah Sow, et al.. (2012). A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project. Trials. 13(1). 61–61. 27 indexed citations
15.
Gninafon, M., et al.. (2010). Exposure to combustion of solid fuel and tuberculosis: a matched case–control study. European Respiratory Journal. 38(1). 132–138. 22 indexed citations
16.
Gninafon, M., et al.. (2004). Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin.. PubMed. 8(10). 1242–7. 15 indexed citations
17.
Dreyfuss, G., D. Rondelaud, Bernard Bouteille, et al.. (1999). [Epidemiological observations on the first case of human paragonimiasis and potential intermediate hosts of Paragonimus sp. in Benin].. PubMed. 92(3). 191–4. 4 indexed citations
18.
Trébucq, Arnaud, et al.. (1999). Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.. PubMed. 3(6). 466–70. 25 indexed citations
19.
Bigot, Adrien, et al.. (1998). [Renal complications associated with human acquired immunodeficiency virus infection in a population of hospital patients at the Hospital and University National Center in Cotonou].. PubMed. 8(4). 283–6. 5 indexed citations
20.
Gninafon, M.. (1989). Evolution of case-finding and treatment of tuberculosis over the last 3 years following the introduction of short-course chemotherapy of 8 months duration in Benin.. PubMed. 64(3). 42–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026